GLUT1-deficiency: barbiturates potentiate haploinsufficiency in vitro
- PMID: 10590023
- DOI: 10.1203/00006450-199912000-00006
GLUT1-deficiency: barbiturates potentiate haploinsufficiency in vitro
Abstract
Barbiturates are known to inhibit glucose transport mediated by the facilitative sugar transporter GLUTI. We have studied such inhibition in children with GLUT1-deficiency. Zero-trans influx of 14C-labeled 3-O-methyl glucose (3OMG) into erythrocytes of patients (n = 3) was 35% of controls (n = 6). Preincubation with 10 mM phenobarbital or pentobarbital reduced patients' 30MG influx to 17%. In patients and controls, preincubation with barbiturates significantly decreased Vmax in a dose-dependent manner (for pentobarbital, IC50 = 0.84 mM, patient 2). The apparent Km in individuals remained largely unchanged. Three-OMG influx without preincubation resulted in a stronger inhibition at lower barbiturate concentrations. The patients' data are discussed in the light of individual missense mutations (patient 1: R126L and K256V; patient 2: T310I; patient 3: S66F) in the GLUTI gene. In conclusion, in controls and patients with GLUT1-deficiency barbiturates interact with GLUT1, lowering its intrinsic activity. The use of barbiturates in this condition for anesthesia or as anticonvulsants could therefore potentially aggravate the existing glucose transport defect and may put these patients at increased risk.
Similar articles
-
Effects of anticonvulsants on GLUT1-mediated glucose transport in GLUT1 deficiency syndrome in vitro.Eur J Pediatr. 2003 Feb;162(2):84-9. doi: 10.1007/s00431-002-1112-8. Epub 2002 Dec 6. Eur J Pediatr. 2003. PMID: 12548383
-
Glucose transporter type 1 deficiency syndrome (Glut1DS): methylxanthines potentiate GLUT1 haploinsufficiency in vitro.Pediatr Res. 2001 Aug;50(2):254-60. doi: 10.1203/00006450-200108000-00015. Pediatr Res. 2001. PMID: 11477212
-
Barbiturate inhibition of GLUT-1 mediated hexose transport in human erythrocytes exhibits substrate dependence for equilibrium exchange but not unidirectional sugar flux.Biochemistry. 1996 Dec 3;35(48):15222-7. doi: 10.1021/bi962050f. Biochemistry. 1996. PMID: 8952470
-
Facilitated glucose transporter protein type 1 (GLUT1) deficiency syndrome: impaired glucose transport into brain-- a review.Eur J Pediatr. 2002 Jun;161(6):295-304. doi: 10.1007/s00431-002-0939-3. Epub 2002 Apr 16. Eur J Pediatr. 2002. PMID: 12029447 Review.
-
Glucose transporter 1 deficiency syndrome and other glycolytic defects.J Child Neurol. 2002 Dec;17 Suppl 3:3S15-23; discussion 3S24-5. J Child Neurol. 2002. PMID: 12597052 Review.
Cited by
-
Glucose Transporter Type I Deficiency (G1D) at 25 (1990-2015): Presumptions, Facts, and the Lives of Persons With This Rare Disease.Pediatr Neurol. 2015 Nov;53(5):379-93. doi: 10.1016/j.pediatrneurol.2015.08.001. Epub 2015 Aug 10. Pediatr Neurol. 2015. PMID: 26341673 Free PMC article. Review.
-
Highlighting membrane protein structure and function: A celebration of the Protein Data Bank.J Biol Chem. 2021 Jan-Jun;296:100557. doi: 10.1016/j.jbc.2021.100557. Epub 2021 Mar 18. J Biol Chem. 2021. PMID: 33744283 Free PMC article. Review.
-
Glut1 Deficiency Syndrome (Glut1DS): State of the art in 2020 and recommendations of the international Glut1DS study group.Epilepsia Open. 2020 Aug 13;5(3):354-365. doi: 10.1002/epi4.12414. eCollection 2020 Sep. Epilepsia Open. 2020. PMID: 32913944 Free PMC article.
-
Total Intravenous Anesthesia in GLUT1 Deficiency Syndrome Patient: A Case Report.Am J Case Rep. 2019 May 5;20:647-650. doi: 10.12659/AJCR.914865. Am J Case Rep. 2019. PMID: 31055589 Free PMC article.
-
Prospective Multicenter Validation of a Simple Blood Test for the Diagnosis of Glut1 Deficiency Syndrome.Neurology. 2023 Jun 6;100(23):e2360-e2373. doi: 10.1212/WNL.0000000000207296. Epub 2023 Apr 19. Neurology. 2023. PMID: 37076312 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous